Open label study to assess efficacy and safety of the fully human anti tumour necrosis factor alpha monoclonal antibody adalimumab
Phase of Trial: Phase III
Latest Information Update: 23 Jun 2016
At a glance
- Drugs Adalimumab; Methotrexate
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- Acronyms PROWD
- Sponsors Abbott Laboratories
- 23 Jun 2016 Results of safety analysis of this and other trials published in the Annals of the Rheumatic Diseases.
- 13 Jun 2009 Results were reported at the 2009 EULAR.
- 16 Apr 2008 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History